The DOI matches its Crossref record.
Lipid-Mediated Folding/Unfolding of Phospholamban as a Regulatory Mechanism for the Sarcoplasmic Reticulum Ca2+-ATPase
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The latter can be explained by the complex folding-unfolding equilibrium for domains Ia and Ib within the membrane [29].”
From Pathological mutations in the phospholamban cytoplasmic region affect its topology and dynamics modulating the extent of SERCA inhibition (2024) · cites this paper as [29]
In the citing paper
“Residual interactions observed for PLN residues Arg13, Arg14, Ser16, and Thr17 with lipid headgroups were abolished with pPLN (Figure 3A), consistent with the correlation between membrane-detachment of domain Ia and reduced inhibition (Gustavsson et al., 2012; Gustavsson et al., 2011).”
From Structural basis for allosteric control of the SERCA-Phospholamban membrane complex by Ca2+ and phosphorylation (2021) · cites this paper as Gustavsson et al., 2011
In the citing paper
“Importantly, these structural ensembles capture the order-disorder dynamics of domain Ib resonances observed in the OS-ssNMR spectra and suggested by previous NMR and EPR studies (Gustavsson et al., 2011).”
From Structural basis for allosteric control of the SERCA-Phospholamban membrane complex by Ca2+ and phosphorylation (2021) · cites this paper as Gustavsson et al., 2011
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
No references could be resolved yet.
Research works printed but not linked: 59
- Simmerman, 1986, Sequence analysis of phospholamban. Identification of phosphorylation sites and two major structural domains, J. Biol. Chem., 261, 13333, 10.1016/S0021-9258(18)69309-3 · doi:10.1016/s0021-9258(18)69309-3
- Reddy, 1999, Depolymerization of phospholamban in the presence of calcium pump: a fluorescence energy transfer study, Biochemistry, 38, 3954, 10.1021/bi981795d · DOI · Paper page
- Tada, 1989, Regulation of the Ca2+ pump ATPase by cAMP-dependent phosphorylation of phospholamban, BioEssays, 10, 157, 10.1002/bies.950100505 · doi:10.1002/bies.950100505
- MacLennan, 2003, Phospholamban: a crucial regulator of cardiac contractility, Nat. Rev., Mol. Cell Biol., 4, 566, 10.1038/nrm1151 · DOI · Paper page
- Stokes, 1990, Three-dimensional crystals of CaATPase from sarcoplasmic reticulum. Symmetry and molecular packing, Biophys. J., 57, 1, 10.1016/S0006-3495(90)82501-7 · DOI
- Toyoshima, 2000, Crystal structure of the calcium pump of sarcoplasmic reticulum at 2.6 Å resolution, Nature, 405, 647, 10.1038/35015017 · DOI · Paper page
- Toyoshima, 2002, Structural changes in the calcium pump accompanying the dissociation of calcium, Nature, 418, 605, 10.1038/nature00944 · DOI · Paper page
- Sorensen, 2004, Phosphoryl transfer and calcium ion occlusion in the calcium pump, Science, 304, 1672, 10.1126/science.1099366 · DOI · Paper page
- Olesen, 2004, Dephosphorylation of the calcium pump coupled to counterion occlusion, Science, 306, 2251, 10.1126/science.1106289 · DOI · Paper page
- Stokes, 2006, Interactions between Ca2+-ATPase and the pentameric form of phospholamban in two-dimensional co-crystals, Biophys. J., 90, 4213, 10.1529/biophysj.105.079640 · doi:10.1529/biophysj.105.079640
- Young, 2001, Locating phospholamban in co-crystals with Ca2+-ATPase by cryoelectron microscopy, Biophys. J., 81, 884, 10.1016/S0006-3495(01)75748-7 · DOI
- Seidel, 2008, Structural characterization of Ca2+-ATPase-bound phospholamban in lipid bilayers by solid-state nuclear magnetic resonance (NMR) spectroscopy, Biochemistry, 47, 4369, 10.1021/bi7024194 · DOI · Paper page
- Schmitt, 2009, Alterations of phospholamban function can exhibit cardiotoxic effects independent of excessive sarcoplasmic reticulum Ca2+-ATPase inhibition, Circulation, 119, 436, 10.1161/CIRCULATIONAHA.108.783506 · DOI
- Cornea, 1997, Mutation and phosphorylation change the oligomeric structure of phospholamban in lipid bilayers, Biochemistry, 36, 2960, 10.1021/bi961955q · DOI · Paper page
- Zamoon, 2003, NMR solution structure and topological orientation of monomeric phospholamban in dodecylphosphocholine micelles, Biophys. J., 85, 2589, 10.1016/S0006-3495(03)74681-5 · DOI
- Traaseth, 2008, Structural and dynamic basis of phospholamban and sarcolipin inhibition of Ca2+-ATPase, Biochemistry, 47, 3, 10.1021/bi701668v · DOI
- Traaseth, 2009, Structure and topology of monomeric phospholamban in lipid membranes determined by a hybrid solution and solid-state NMR approach, Proc. Natl Acad. Sci. USA, 106, 10165, 10.1073/pnas.0904290106 · DOI · Paper page
- Mascioni, 2002, Solid-state NMR and rigid body molecular dynamics to determine domain orientations of monomeric phospholamban, J. Am. Chem. Soc., 124, 9392, 10.1021/ja026507m · doi:10.1021/ja026507m
- Metcalfe, 2004, H/15N heteronuclear NMR spectroscopy shows four dynamic domains for phospholamban reconstituted in dodecylphosphocholine micelles, Biophys. J., 87, 1205, 10.1529/biophysj.103.038844 · DOI
- Zamoon, 2005, Mapping the interaction surface of a membrane protein: unveiling the conformational switch of phospholamban in calcium pump regulation, Proc. Natl Acad. Sci. USA, 102, 4747, 10.1073/pnas.0406039102 · DOI
- Karim, 2006, Phosphorylation-dependent conformational switch in spin-labeled phospholamban bound to SERCA, J. Mol. Biol., 358, 1032, 10.1016/j.jmb.2006.02.051 · DOI · Paper page
- Nesmelov, 2007, Rotational dynamics of phospholamban determined by multifrequency electron paramagnetic resonance, Biophys. J., 93, 2805, 10.1529/biophysj.107.108910 · DOI
- Metcalfe, 2005, Serine 16 phosphorylation induces an order-to-disorder transition in monomeric phospholamban, Biochemistry, 44, 4386, 10.1021/bi047571e · DOI
- Traaseth, 2006, Effects of Ser16 phosphorylation on the allosteric transitions of phospholamban/Ca2+-ATPase complex, J. Mol. Biol., 358, 1041, 10.1016/j.jmb.2006.02.047 · DOI
- Hughes, 2009, Cytoplasmic residues of phospholamban interact with membrane surfaces in the presence of SERCA: a new role for phospholipids in the regulation of cardiac calcium cycling?, Biochim. Biophys. Acta, 1788, 559, 10.1016/j.bbamem.2008.10.029 · doi:10.1016/j.bbamem.2008.10.029
- Abu-Baker, 2006, Phospholamban and its phosphorylated form interact differently with lipid bilayers: a 31P, 2H, and 13C solid-state NMR spectroscopic study, Biochemistry, 45, 13312, 10.1021/bi0614028 · DOI · Paper page
- Chu, 2010, N Solid-state NMR spectroscopic studies on phospholamban at its phosphorylated form at ser-16 in aligned phospholipid bilayers, Biochim. Biophys. Acta, 1798, 312, 10.1016/j.bbamem.2009.12.020 · doi:10.1016/j.bbamem.2009.12.020
- Wegener, 1989, Phospholamban phosphorylation in intact ventricles. Phosphorylation of serine 16 and threonine 17 in response to β-adrenergic stimulation, J. Biol. Chem., 264, 11468, 10.1016/S0021-9258(18)60487-9 · DOI · Paper page
- Ha, 2007, Controlling the inhibition of the sarcoplasmic Ca2+-ATPase by tuning phospholamban structural dynamics, J. Biol. Chem., 282, 37205, 10.1074/jbc.M704056200 · DOI
- Hoshijima, 2002, Chronic suppression of heart-failure progression by a pseudophosphorylated mutant of phospholamban via in vivo cardiac rAAV gene delivery, Nat. Med., 8, 864, 10.1038/nm739 · DOI · Paper page
- Karim, 2000, Synthetic null-cysteine phospholamban analogue and the corresponding transmembrane domain inhibit the Ca-ATPase, Biochemistry, 39, 10892, 10.1021/bi0003543 · DOI
- Clayton, 2005, Spectroscopic studies of phospholamban variants in phospholipid bilayers, Biochem. Soc. Trans., 33, 913, 10.1042/BST20050913 · doi:10.1042/bst20050913
- Lockwood, 2003, Structure and function of integral membrane protein domains resolved by peptide-amphiphiles: application to phospholamban, Biopolymers, 69, 283, 10.1002/bip.10365 · doi:10.1002/bip.10365
- Hubbard, 1994, Conformation of the cytoplasmic domain of phospholamban by NMR and CD, Mol. Membr. Biol., 11, 263, 10.3109/09687689409160436 · doi:10.3109/09687689409160436
- Huggins, 1987, Evidence for a phosphorylation-induced conformational change in phospholamban from the effects of three proteases, FEBS Lett., 217, 32, 10.1016/0014-5793(87)81236-X · doi:10.1016/0014-5793(87)81236-x
- Ladokhin, 1999, Folding of amphipathic α-helices on membranes: energetics of helix formation by melittin, J. Mol. Biol., 285, 1363, 10.1006/jmbi.1998.2346 · DOI · Paper page
- White, 1999, Membrane protein folding and stability: physical principles, Annu. Rev. Biophys. Biomol. Struct., 28, 319, 10.1146/annurev.biophys.28.1.319 · DOI · Paper page
- D'Onofrio, 2009, NMR unfolding studies on a liver bile acid binding protein reveal a global two-state unfolding and localized singular behaviors, Arch. Biochem. Biophys., 481, 21, 10.1016/j.abb.2008.10.017 · DOI
- Zhang, 2003, RefDB: a database of uniformly referenced protein chemical shifts, J. Biomol. NMR, 25, 173, 10.1023/A:1022836027055 · DOI · Paper page
- Li, 2008, Internal dynamics control activation and activity of the autoinhibited Vav DH domain, Nat. Struct. Mol. Biol., 15, 613, 10.1038/nsmb.1428 · DOI
- Traaseth, 2010, Probing excited states and activation energy for the integral membrane protein phospholamban by NMR CPMG relaxation dispersion experiments, Biochim. Biophys. Acta, 1798, 77, 10.1016/j.bbamem.2009.09.009 · DOI · Paper page
- MacLennan, 1998, Sites of regulatory interaction between calcium ATPases and phospholamban, Ann. N. Y. Acad. Sci., 853, 31, 10.1111/j.1749-6632.1998.tb08254.x · doi:10.1111/j.1749-6632.1998.tb08254.x
- Andronesi, 2005, Determination of membrane protein structure and dynamics by magic-angle-spinning solid-state NMR spectroscopy, J. Am. Chem. Soc., 127, 12965, 10.1021/ja0530164 · DOI · Paper page
- Stevenson, 2003, Clinical use of inotropic therapy for heart failure: looking backward or forward? Part II: chronic inotropic therapy, Circulation, 108, 492, 10.1161/01.CIR.0000078349.43742.8A · DOI
- Wright, 2009, Linking folding and binding, Curr. Opin. Struct. Biol., 19, 31, 10.1016/j.sbi.2008.12.003 · DOI · Paper page
- Mittag, 2009, Protein dynamics and conformational disorder in molecular recognition, J. Mol. Recognit., 23, 105, 10.1002/jmr.961 · DOI · Paper page
- Yao, 2008, Estimation of the available free energy in a LOV2-Jα photoswitch, Nat. Chem. Biol., 4, 491, 10.1038/nchembio.99 · DOI · Paper page
- Buck, 2003, Overexpression, purification, and characterization of recombinant Ca-ATPase regulators for high-resolution solution and solid-state NMR studies, Protein Expr. Purif., 30, 253, 10.1016/S1046-5928(03)00127-X · DOI · Paper page
- Masterson, 2009, Expression and purification of isotopically labeled peptide inhibitors and substrates of cAMP-dependant protein kinase A for NMR analysis, Protein Expression Purif., 64, 231, 10.1016/j.pep.2008.10.016 · doi:10.1016/j.pep.2008.10.016
- Yonemoto, 1991, Prokaryotic expression of catalytic subunit of adenosine cyclic monophosphate-dependent protein kinase, Methods Enzymol., 200, 581, 10.1016/0076-6879(91)00173-T · doi:10.1016/0076-6879(91)00173-t
- Masterson, 2008, Allosteric cooperativity in protein kinase A, Proc. Natl Acad. Sci. USA, 105, 506, 10.1073/pnas.0709214104 · DOI · Paper page
- Reddy, 2003, Defining the molecular components of calcium transport regulation in a reconstituted membrane system, Biochemistry, 42, 4585, 10.1021/bi026995a · DOI · Paper page
- Karim, 2004, Phospholamban structural dynamics in lipid bilayers probed by a spin label rigidly coupled to the peptide backbone, Proc. Natl Acad. Sci. USA, 101, 14437, 10.1073/pnas.0402801101 · doi:10.1073/pnas.0402801101
- Delaglio, 1995, NMRPipe: a multidimensional spectral processing system based on UNIX pipes, J. Biomol. NMR, 6, 277, 10.1007/BF00197809 · DOI · Paper page
- Kay, 1992, Pure absorption gradient enhanced heteronuclear single quantum correlation spectroscopy with improved sensitivity, J. Am. Chem. Soc., 114, 10663, 10.1021/ja00052a088 · DOI · Paper page
- Farrow, 1994, Backbone dynamics of a free and phosphopeptide-complexed Src homology 2 domain studied by 15N NMR relaxation, Biochemistry, 33, 5984, 10.1021/bi00185a040 · DOI · Paper page
- Lin, 2002, Clean SEA-HSQC: a method to map solvent exposed amides in large non-deuterated proteins with gradient-enhanced HSQC, J. Biomol. NMR, 23, 317, 10.1023/A:1020225206644 · doi:10.1023/a:1020225206644
- Mori, 1996, Separation of intramolecular NOE and exchange peaks in water exchange spectroscopy using spin-echo filters, J. Biomol. NMR, 7, 77, 10.1007/BF00190459 · doi:10.1007/bf00190459
- Hwang, 1998, Accurate quantitation of water–amide proton exchange rates using the phase-modulated CLEAN chemical EXchange (CLEANEX-PM) approach with a Fast-HSQC (FHSQC) detection scheme, J. Biomol. NMR, 11, 221, 10.1023/A:1008276004875 · DOI · Paper page
Cited by
Weber, D. K., Reddy, U. V., Wang, S., Larsen, E. K., Gopinath, T., Gustavsson, M. B., Cornea, R. L., Thomas, D. D., De Simone, A., & Veglia, G. (2021) · eLife · doi:10.7554/elife.66226 · Cited by 51
Self-citationGopinath, T., & Veglia, G. (2018) · Methods · doi:10.1016/j.ymeth.2018.07.003 · Cited by 24
Self-citationWeber, D. K., Reddy, U. V., Robia, S. L., & Veglia, G. (2024) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2024.184370 · Cited by 8
Self-citationMet125 is essential for maintaining the structural integrity of calmodulin’s C-terminal domain
Nelson, S. E. D., Weber, D. K., Rebbeck, R. T., Cornea, R. L., Veglia, G., & Thomas, D. D. (2020) · Scientific Reports · doi:10.1038/s41598-020-78270-w · Cited by 2
Self-citation
Metadata
- Authors
- Gustavsson, M., Traaseth, N. J., Karim, C. B., Lockamy, E. L., Thomas, D. D., & Veglia, G.
- Venue
- Journal of Molecular Biology
- Publisher
- Elsevier BV
- Published
- 2011-05
- Volume
- 408
- Issue
- 4
- Pages
- 755-765
- ISSN
- 0022-2836
- Cited by
- 48
- References
- 0
- Language
- en
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- Funders
- GV (GM64742)
- DDT (GM27906)
- American Heart Association (10PRE3860050)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.